Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:HYBTNASDAQ:QTINYSE:RVPOTCMKTS:SIGY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHYBTHeyu Biological Technology$0.20$0.25$0.00▼$3.40$20.91M-17.745,371 shs20 shsQTIQT Imaging$0.79-0.1%$0.58$0.35▼$0.97$21.44M-0.2154,161 shs146,382 shsRVPRetractable Technologies$0.74+0.7%$0.73$0.56▼$1.22$22.16M1.6579,597 shs33,081 shsSIGYSigyn Therapeutics$3.53$4.04$3.15▼$6.34$5.67M-1.04436 shsN/A13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHYBTHeyu Biological Technology0.00%0.00%+20.18%+60.71%-9.03%QTIQT Imaging+5.33%+8.22%+31.67%+97.99%-1.86%RVPRetractable Technologies0.00%-1.33%+6.78%-10.19%-31.48%SIGYSigyn Therapeutics0.00%0.00%-14.94%+10.31%-35.82%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHYBTHeyu Biological TechnologyN/AN/AN/AN/AN/AN/AN/AN/AQTIQT ImagingN/AN/AN/AN/AN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/AN/AN/AN/AN/ASIGYSigyn TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHYBTHeyu Biological Technology 0.00N/AN/AN/AQTIQT Imaging 0.00N/AN/AN/ARVPRetractable Technologies 0.00N/AN/AN/ASIGYSigyn Therapeutics 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHYBTHeyu Biological Technology$80K261.34N/AN/A$0.38 per share0.53QTIQT Imaging$4.00M5.36N/AN/A($1.91) per share-0.41RVPRetractable Technologies$33.05M0.67$0.02 per share48.25$3.31 per share0.22SIGYSigyn TherapeuticsN/AN/AN/AN/A($2.80) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHYBTHeyu Biological Technology-$270KN/A0.00∞N/A-453.55%-6.43%-4.43%N/AQTIQT Imaging-$4.03MN/A0.00∞N/AN/AN/A-65.94%5/8/2025 (Estimated)RVPRetractable Technologies-$7.01M-$0.41N/A∞N/A-41.11%-17.15%-9.33%N/ASIGYSigyn Therapeutics-$4.15M-$4.77N/A∞N/AN/AN/A-1,147.41%N/ALatest SIGY, RVP, HYBT, and QTI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/15/2025Q4 2024SIGYSigyn TherapeuticsN/A-$2.51N/A-$2.51N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHYBTHeyu Biological TechnologyN/AN/AN/AN/AN/AQTIQT ImagingN/AN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/AN/ASIGYSigyn TherapeuticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHYBTHeyu Biological TechnologyN/A0.350.34QTIQT ImagingN/A1.060.48RVPRetractable Technologies0.018.575.92SIGYSigyn TherapeuticsN/A0.060.05Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHYBTHeyu Biological TechnologyN/AQTIQT Imaging24.19%RVPRetractable Technologies7.58%SIGYSigyn Therapeutics10.01%Insider OwnershipCompanyInsider OwnershipHYBTHeyu Biological Technology89.24%QTIQT Imaging75.40%RVPRetractable Technologies57.10%SIGYSigyn Therapeutics78.46%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHYBTHeyu Biological Technology6103.25 million11.11 millionNot OptionableQTIQT ImagingN/A27.13 million6.68 millionN/ARVPRetractable Technologies24029.94 million13.47 millionOptionableSIGYSigyn Therapeutics51.61 million346,000Not OptionableSIGY, RVP, HYBT, and QTI HeadlinesRecent News About These CompaniesSigyn Therapeutics Delays Yearly Report FilingMarch 31, 2025 | tipranks.comSigyn CEO Note: An Emerging New Industry, 15 Years in the MakingMarch 12, 2025 | finance.yahoo.comSigyn CEO Note: Combating the Rising Threat of New Pandemic VirusesMarch 5, 2025 | finance.yahoo.comSigyn Therapeutics to be Featured in Fireside Chat With Zacks Healthcare AnalystFebruary 25, 2025 | finance.yahoo.comSigyn Therapeutics to Present at Tomorrow’s Small Cap Growth Virtual Investor ConferenceFebruary 5, 2025 | financialpost.comSigyn Therapeutics to Present at Tomorrow's Small Cap Growth Virtual Investor ConferenceFebruary 5, 2025 | globenewswire.comSigyn Therapeutics Announces the Appointment of Michael Ryan to Its Board of DirectorsJanuary 29, 2025 | finance.yahoo.comSigyn Therapeutics, Inc. (SIGY)December 21, 2024 | finance.yahoo.comPresenting on the Emerging Growth Conference 76 Day 2 on October 31 Register NowOctober 30, 2024 | markets.businessinsider.comPresenting on the Emerging Growth Conference 74 Day 2 on August 22 Register NowAugust 21, 2024 | finance.yahoo.comOTCQB Venture Virtual Investor Conference Presentations Now Available for On-Demand ViewingAugust 2, 2024 | finance.yahoo.comSigyn Therapeutics Reports First Quarter 2024 Financial ResultsMay 15, 2024 | finance.yahoo.comSigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"May 7, 2024 | finance.yahoo.comSigyn Therapeutics™ to Present at Tomorrow’s Emerging Growth ConferenceMarch 5, 2024 | finance.yahoo.comSigyn Therapeutics to Present at Tomorrow's Emerging Growth ConferenceMarch 5, 2024 | finance.yahoo.comSigyn Therapeutics™ to Present at Tomorrow's Emerging Growth ConferenceMarch 5, 2024 | globenewswire.comSigyn Therapeutics™ Announces Filing of 2023 Annual Report on SEC Form 10-KFebruary 21, 2024 | globenewswire.comSigyn Therapeutics, Inc.: Sigyn Therapeutics Completes Reverse Stock SplitFebruary 3, 2024 | finanznachrichten.deSigyn Therapeutics Announces 1-for-40 Reverse Stock SplitFebruary 2, 2024 | msn.comSigyn Therapeutics Completes Reverse Stock SplitFebruary 1, 2024 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSIGY, RVP, HYBT, and QTI Company DescriptionsHeyu Biological Technology OTCMKTS:HYBT$0.20 0.00 (0.00%) As of 05/2/2025Hong Chang Biotechnologies (HK) Limited was incorporated in 2023 and is based in Kowloon, Hong Kong. Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Zengqiang Investment Limited. As of September 4, 2023, Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Heyu Biological Technology Corporation.QT Imaging NASDAQ:QTI$0.79 0.00 (-0.13%) As of 05/2/2025QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.Retractable Technologies NYSE:RVP$0.74 +0.01 (+0.74%) As of 05/2/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.Sigyn Therapeutics OTCMKTS:SIGY$3.53 0.00 (0.00%) As of 05/2/2025Sigyn Therapeutics, Inc., a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats. The company is also involved in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. In addition, it develops ChemoPrep to enhance the tumor site delivery of chemotherapy; ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis; and ImmunePrep to enhance the potential efficacy of immunotherapeutic antibodies. Sigyn Therapeutics, Inc. was founded in 2019 and is headquartered in San Diego, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 04/28 - 05/02 Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be Cautious Meta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2 Why Spotify Stock Still Has Room to Run in 2025 Is It Time to Load Up on Bond ETFs? Palantir Earnings: 1 Bullish Signal and 1 Area of Concern Roblox Stock Gains Momentum and Can Top $100 in 2025 Visa Q2 Earnings Top Forecasts, Adds $30B Buyback Plan Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
